MEDICATION TREATMENT STRATEGIES IN THE MTA STUDY: RELEVANCE TO CLINICIANS AND RESEARCHERS
Kaydedildi:
GREENHILL, L.L., ET AL., MEDICATION TREATMENT STRATEGIES IN THE MTA STUDY: RELEVANCE TO CLINICIANS AND RESEARCHERS. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, Vol. 35, no. 10 (1996), p. 1304-1313.
Ref.
53235
Yer:
SIIS SIIS Madrid R.598
Palabras clave:
Fármacos, Hiperactividad, Infancia, Trastornos de atención, Tratamiento médico
Fármacos, Hiperactividad, Infancia, Trastornos de atención, Tratamiento médico
Özet:
-
-
Benzer Materyaller: MEDICATION TREATMENT STRATEGIES IN THE MTA STUDY: RELEVANCE TO CLINICIANS AND RESEARCHERS
- STIMULANT MEDICATIONS
- CHILD AND FAMILY CHARACTERISTICS AS PREDICTORS AND OUTCOMES IN THE MULTIMODAL TREATMENT STUDY OF ADHD (MTA STUDY)
- SUMMARY OF THE PRACTICE PARAMETER FOR THE USE OF STIMULANT MEDICATIONS IN THE TREATMENT OF CHILDREN, ADOLESCENTS, AND ADULTS
- Motor skills of children newly diagnosed with attention deficit hyperactivity disorder prior to and following treatment with stimulant medication
- A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ADDERALL AND METHYLPHENIDATE IN THE TREATMENT OF ATTENTION-DEFICIT / HYPERACTIVITY DISORDER
- BUPROPION VERSUS METHYLPHENIDATE IN THE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER